【摘要】 目的:探讨小肾癌的临床特征。方法:对我院收治的 43 例小肾癌(直径≤3 cm)患者(小肾癌组)和153例肾癌(直径>3cm)患者(大肾癌组)的临床资料进行对比。结果:小肾癌临床分期低,两组差异显著(P<0.01),两组病理分类无统计学意义(P>0.05)。两组 3 年生存率分别为96.3%和69.8%(P<0.01),5 年生存率分别为93.8%和63.6%(P<0.05)。结论:小肾癌比大肾癌临床分期低,预后较好,生存率高。保留肾单位的手术为小肾癌治疗的较好选择。更多还原

【Abstract】 Objective:To explore the clinical characteristics of small renal cell carcinoma.Methods:We compared the clinical data of 43 cases with small renal cell carcinoma (≤3 cm) and 153 cases with renal cell carcinoma (>3 cm).Results:The small renal cell carcinoma has lower clinical stage and the two group have significant difference (P< 0.01). The pathological classification has no statistical difference between the two groups. The 3-year survival rate was 96.3% and 69.8%(P< 0.01), 5-year survival rate was 93.8% and 63.6% (P< 0.05) respectively in the two groups.Conclusions:The small renal cell carcinoma has lower clinical stage, better prognosis and higher survival rate. Nephron-sparing surgery (NSS) is an effective means in treatment of small renal cell carcinoma.更多还原